ID: ALA319073

Max Phase: Preclinical

Molecular Formula: C8H6F3NO2

Molecular Weight: 205.14

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(N(O)c1ccccc1)C(F)(F)F

Standard InChI:  InChI=1S/C8H6F3NO2/c9-8(10,11)7(13)12(14)6-4-2-1-3-5-6/h1-5,14H

Standard InChI Key:  NQUCPZLKPQFTEO-UHFFFAOYSA-N

Associated Targets(non-human)

Aldehyde dehydrogenase 1A1 96 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 205.14Molecular Weight (Monoisotopic): 205.0351AlogP: 1.97#Rotatable Bonds: 1
Polar Surface Area: 40.54Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.43CX Basic pKa: CX LogP: 1.98CX LogD: 1.70
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.56Np Likeness Score: -0.78

References

1. Conway TT, DeMaster EG, Lee MJ, Nagasawa HT..  (1998)  Prodrugs of nitroxyl and nitrosobenzene as cascade latentiated inhibitors of aldehyde dehydrogenase.,  41  (15): [PMID:9667978] [10.1021/jm980200+]

Source